Dr. Thomas L. Kerr, MD

Dr. Kerr practices at Cogdell Memorial Hospital in Snyder, Texas, part of Cogdell Memorial Hospital.

Dr. Kerr's NPI, 1831156280, was assigned on April 28, 2006. Dr. Kerr graduated from University of Ottawa Faculty of Medicine in 1975. Dr. Kerr holds Texas license J6145.

Dr. Kerr's primary practice is Cogdell Memorial Hospital, at 1700 Cogdell Blvd, Snyder, TX 79549 in Scurry County. The practice phone is (325) 574-7437.

Dr. Kerr's primary practice is Cogdell Memorial Hospital in Snyder, Texas, part of Cogdell Memorial Hospital. The medical group on file is Cogdell Memorial Hospital. Dmand AI also links Dr. Kerr to 1 more medical group, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Kerr practices. Vendor and product names are available with a free account.

Internal medicine is Dr. Kerr's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Kerr is board certified in internal medicine by the American Board of Internal Medicine. Dr. Kerr is licensed in Texas.

Dmand AI lists acute gastroduodenitis, acute skin infection, chronic diabetes, chronic obstructive pulmonary disease (COPD), coronary artery disease, fluid and electrolyte imbalances, gastrointestinal bleeding and kidney failure among the conditions Dr. Kerr treats.

CMS data shows 64 Medicare services from Dr. Kerr across 2 procedure codes in 2024, for 66 Medicare patients. Medicare paid $7,580 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 66 Medicare patients who saw Dr. Kerr in 2024. The largest group is 65 to 74, with 27 patients. 75% of them have high blood pressure, and 75% have high cholesterol. Their average risk score is 1.43, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Kerr's median patient age at 72, with 49% women.

In 2024, Dr. Kerr wrote 349 Medicare Part D claims for 58 patients. 83% of them were for generic drugs. CMS names the drug for 154 of them, across 9 drugs with 11 or more claims each, at $3,824 in total drug cost. In 2023, CMS named 1,790 claims across 54 drugs.

Dmand AI links 2 papers to Dr. Kerr. The most frequent topics are Coliphages, Escherichia coli and Ultraviolet Rays. Dr. Kerr has published most often in Mutat Res.

CMS Open Payments shows 148 general payments to Dr. Kerr from 16 drug and device companies from 2016 to 2022. Honoraria make up the largest share, 31% of the total. Alexion Pharmaceuticals, Inc. paid the most, $19,534.

Dr. Kerr graduated from University of Ottawa Faculty of Medicine in 1975.

Dr. Kerr is in network with 19 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Elevance. PPO plans come from the most carriers, 12. Check the plan with the practice before a visit.